AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2021
Jul 2, 2021
35021_dirs_2021-07-02_e4787f0d-94e4-4815-9cee-cd428360b0e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2021-06-23
Reporting Person: Chanan-Khan Asher (Director)
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 4